Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
ms-553 (1 trial)
telatinib mesylate (1 trial)
Diabetes Mellitus (Phase 1)
Diabetic Retinopathy (Phase 1)
Edema (Phase 1)
Macular Edema (Phase 1)
Neoplasms (Phase 1)
Retinal Diseases (Phase 1)
Trials (2 total)
Trial APIs (2 total)